Rani imagines a world without needles: Rani Therapeutics is a clinical-stage biotherapeutics company developing technology to enable orally administered biologics and drugs.
A new way of drug delivery: RaniPill® addresses the 30-year-old "gastric barrier" problem. Instead of using chemical absorption methods that provide less than 1 percent bioavailability, Rani has created a simple-to-swallow robotic capsule that delivers biologics through the intestinal wall, offering injectable-like bioavailability without a needle.
Potential to make therapies better, not just more convenient: By delivering the same API dose as an injection, we eliminate the trade-off between oral convenience and clinical performance. We have demonstrated this ability in humans with the first oral monoclonal antibody to reach high bioavailability. This creates a unique opportunity to maintain or even enhance the efficacy and safety profiles of established biologics while optimizing dosing and reducing variability.
